Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13

Trial Status

Completed1
Recruiting1
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04762199Phase 1Recruiting
MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer
Advanced Lung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8+2 more
PrincipalinvestigatorStart date: 2021-02-24
NCT03690986Phase 1Active Not Recruiting
VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer
Squamous Cell Carcinoma of the Head and Neck
PrincipalinvestigatorStart date: 2018-11-01

Research Network

Collaboration Network

9 collaborators·36 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Aung Naing, Md

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Solid TumorMetastatic Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score21%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Solid TumorStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score17%

Jason Henry, MD

Sarah Cannon Research Institute at HealthONE

Related
1 trials

Shared therapeutic areas:

Solid Tumor

Worked with same sponsors:

Sirnaomics
Collaborated on 1 trial
Similarity Score14%

Anthony El-Khoueiry, MD

University of Southern California

Related
6 trials

Shared therapeutic areas:

Solid Tumor

Worked with same sponsors:

National Cancer Institute (NCI)Sirnaomics
Collaborated on 1 trial
Similarity Score14%

Hani Babiker, MD

Mayo Clinic

Related
1 trials

Shared therapeutic areas:

Solid Tumor

Worked with same sponsors:

Sirnaomics
Collaborated on 1 trial
Similarity Score14%

Michael Cecchini, MD

Yale University

Related
1 trials

Shared therapeutic areas:

Solid Tumor

Worked with same sponsors:

Sirnaomics
Collaborated on 1 trial
Similarity Score14%

Angela Alistar, MD

Atlantic Health System

Related
1 trials

Shared therapeutic areas:

Solid Tumor

Worked with same sponsors:

Sirnaomics
Collaborated on 1 trial
Similarity Score14%

Andrae Vandross, MD

NEXT Oncology

Related
1 trials

Shared therapeutic areas:

Solid Tumor

Worked with same sponsors:

Sirnaomics
Collaborated on 1 trial
Similarity Score14%

Zhaohui Jin, MD

Mayo Clinic

Related
1 trials

Shared therapeutic areas:

Solid Tumor

Worked with same sponsors:

Sirnaomics
Collaborated on 1 trial
Similarity Score14%

Christina Wu, MD

Mayo Clinic

Related
1 trials

Shared therapeutic areas:

Solid Tumor

Worked with same sponsors:

Sirnaomics
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05037149Phase 1PrincipalInvestigator

Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors

Solid Tumor
Completed
NCT04762199Phase 1PrincipalInvestigator

MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer

Advanced Lung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8+2 more
Recruiting
NCT03690986Phase 1PrincipalInvestigator

VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer

Squamous Cell Carcinoma of the Head and Neck
Active Not Recruiting

All 3 trials loaded